The World Health Organization (WHO) and its partners have agreed to launch a programme for claims of serious side effects among people in 92 poorer countries due to Covid-19 vaccination, the WHO said Monday in a statement.
"This is the first and only global vaccine injury compensation mechanism" operating on an international scale, the WHO statement said.
According to WHO, the programme, No-Fault Compensation, will offer eligible individuals "a fast, fair, robust and transparent process to receive compensation for rare but serious adverse events associated with COVAX-distributed vaccines until June 30 2022."
COVAX is a facility led by WHO for better Covid-19 vaccine distribution. The statement said all vaccines procured or distributed through COVAX receive regulatory approval or an emergency use authorization to confirm their safety and efficacy.
"But, as with all medicines, even vaccines that are approved for general use may, in rare cases, cause serious adverse reactions," WHO said.
"By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process," said the statement.
By providing a mechanism to settle serious adverse events, the compensation program could help those who might have such effects, and help manufacturers to roll out vaccines to countries faster, said Seth Berkley, CEO of the Vaccine Alliance Gavi, in the statement.
The programme will be operated by ESIS, a subsidiary of the Zurich-based multinational insurance company Chubb Limited, the WHO said, adding that the compensation mechanism is to be funded by Gavi through a "levy charged on all doses of Covid-19 vaccines distributed through the COVAX Facility".
WHO Director-General Tedros Adhanom Ghebreyesus praised the agreement, saying that this agreement offers further protection and confidence in the life-saving power of vaccines.
As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 251 candidate vaccines are still being developed worldwide -- 70 of them in clinical trials - in countries including Germany, China, Russia, Britain and the United States, according to information released by WHO on February 19.
Latest Stories
-
Easter celebration: Ghana AIDS Commission to distribute free condoms in Kwahu
14 mins -
Zeepay secures additional $3m from Verdant Capital Hybrid Fund
21 mins -
Over 70% of power outages were due to planned maintenance works – ECG to PURC
24 mins -
Access Bank partners Horseman Shoes to boost local shoe manufacturing industry
35 mins -
Election 2024: Don’t vote for candidates making empty promises – CDD to Ghanaians
40 mins -
IGP shares Easter safety tips on Adom FM’s ‘Ofie Kwanso’
1 hour -
Ebo Whyte offers fully-funded trip as he unveils new play ‘Dubai or No Sex’
1 hour -
Ancient culture of Anlo Kingdom: Exploring “Torkor Atorlia,” the fifth landing stage’s old ways of punishment
2 hours -
Leaders from Saudi Arabia, Turkey, Botswana, Cameroon and Sierra Leone to lead discussions at Africa Finance Corporation’s (AFC) 4th Country & Stakeholder Symposium
2 hours -
Network International Delivers Strong 2023 Revenue growth at 15% y/y and free cashflow growth of 16% y/y
2 hours -
President Akufo-Addo extends Easter Greetings to Ghanaians, urges safe drive
2 hours -
Government pushes for use of more local materials in housing, other infrastructure projects
3 hours -
Dr Bawumia extends Easter greetings to Christians
3 hours -
CAF Confederation Cup: ‘Ghanaians should expect victory against Stade Malien’ – Dreams FC forward Ishmael Dede
3 hours -
CAF Confederation Cup: ‘We want to go there and win’ – Karim Zito on Stade Malian clash
4 hours